Toward Novel Vaccines Against Tuberculosis: Current Hopes and Obstacles | Yale Journal of Biology and Medicine

Alternative cross-priming through CCL17-CCR4- mediated attraction of CTLs toward NKT cell–licensed DCs | Nature Immunology